Skip to main content
SpringerLink
Log in

Who is treated, and how, for depression?

An analysis of statutory health insurance data in Germany

  • ORIGINAL PAPER
  • Published:
Social Psychiatry and Psychiatric Epidemiology Aims and scope Submit manuscript

Abstract

Background

Studies on the treatment of depression using epidemiological survey methods suggest a high level of under-treatment. Little is known about the characteristics of those people receiving treatment and indeed what kind of treatment they are likely to receive.

Method

Analysis of the data of a statutory health insurance company in Germany.

Results

In middle-aged groups, about 50% of those diagnosed as being depressed in outpatient care are prescribed antidepressants and/or psychotherapy in the course of a year. There is more pharmacologic treatment provided in rural areas and more psychotherapy in cities, suggesting that treatment is dependent upon service availability rather than evidence-based treatment decisions. Treatment rates are considerably lower in the very young and the very old and show gender bias. Young females receive less pharmacologic treatment than young males, and elderly men are, in general, treated less than women, suggesting under-treatment at least for these groups.

Conclusions

The low treatment rates following the diagnosis of depression in the young and the old require attention, in particular with respect to gender aspect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Notes

  1. Only one main diagnosis can be coded for patients admitted to hospital. It usually indicates the main reason for admission. Beyond this, numerous secondary diagnosis can be added, indicating comorbidity

References

  1. Alonso J, Angermeyer M, Bernert S, Bruffaerts R, Brugha T, Bryson H, de Giralamo G, de Graaf R, Demyttenaere K, Gasquet I, Haro J, Katz S, Kessler R, Kovess V, Lepine J, Ormel J, Polidori G, Rousso J, Vilagut G (2004) Psychotropic drug utilization in Europe: results from the European study of the epistemology of mental disorders (ESEMeD) project. Acta Psychiatr Scand 109(Suppl 420):55–64

    Google Scholar 

  2. Alonso J, Angermeyer M, Bernert S, Bruffaerts R, Brugha T, Bryson H, de Giralamo G, de Graaf R, Demyttenaere K, Gasquet I, Haro J, Katz S, Kessler R, Kovess V, Lepine J, Ormel J, Polidori G, Rousso J, Vilagut G (2004) Use of mental health services in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand 109(Suppl 420):47–54

    Google Scholar 

  3. Andrews G, Sanderson K, Corry J, Lapsley H (2000) Using epidemiological data to model efficiency in reducing the burden of depression. J Ment Health Policy Econ 3:175–186

    Article  PubMed  Google Scholar 

  4. Bramesfeld A, Grobe T, Schwartz F (2007) Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data. Euro J Epidemiology DOI 10.1007/s10654-007-9128-z

  5. Busch S, Leslie D, Rosenheck R (2004) Measuring quality of psychopharmacotherapy for depression in a national health care system. Med Care 42:532–542

    Article  PubMed  Google Scholar 

  6. Busse R, Riesberg A (2004) Health care systems in transition: Germany. Copenhagen WHO regional office for Europe on behalf of the European observatory on health systems and policies

  7. Fegert J, Kölch M, Zito J, Glaeske G, Janhsen K (2006) Antidepressants use in children and adolescents in Germany. J Clin Child Adolesc Psychopharmacol 16:197–206

    Article  Google Scholar 

  8. Fernández A, Haro J, Martinez-alonso K, Demyttenaere K, Brugha T, Autonell G, de Giralamo G, Bernert S, Lépine J, Alonso J (2007) Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry 190:172–173

    Article  PubMed  Google Scholar 

  9. Fiedler G (2005) Suizide, Suizidversuche und Suizidalität in Deutschland. Daten und Fakten 2003. http://www.uke.uni-hamburg.de/extern/tzs/online-text/daten.pdf

  10. Freudenstein U, Jagger C, Arthur A, Donner-Banzhoff N (2001) Treatment for late life depression in primary care—a systematic review. Fam Pract 18:321–327

    Article  PubMed  CAS  Google Scholar 

  11. Friemel S, Bernert S, Angermeyer M, König H (2005) Die direkten Kosten von depressiven Erkrankungen in Deutschland. Ergebnisse aus dem European study of the epidemiology of mental disorders (ESEMeD) Projekt. Psych Prax 32:113–121

    Article  Google Scholar 

  12. Grobe T, Bramesfeld A, Schwartz F (2006) Versorgungsgeschehen. Analyse von Krankenhausdaten. In: Stoppe G, Bramesfeld A, Schwartz F (eds) Volkskrankheit Depression? Bestandsaufnahme und Perspektiven. Springer, Berlin, Heidelberg, pp 39–98

  13. Grobe T, Dörning H, Schwartz F (2004) GEK-Gesundheitsreport 2004. Schwerpunktthema: Gesundheitsstörungen durch Alkohol. St. Augustin Asgard-Verlag

  14. Harrington R, Whittaker J, Shoebridge P, Campbell F (1998) Systematic review of efficacy of cognitive behavior therapy in childhood and adolescent depressive disorder. BMJ 23:1559–1563

    Google Scholar 

  15. Hazell P, O’Connell D, Heathcote D, Henry D (2004) Trizyclic drugs for depression in children and adolescents. The Cochrane Library

  16. Hunkeler E, Katon W, Tang L, Williams J, Kroenke K, Lin E, Harpole L, Arean P, Levine S, Grypma L, Hargreaves W, Unützer J (2006) Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ 332:259–263

    Article  PubMed  Google Scholar 

  17. Kessler R, Demler O, Frank R, Olfson M, Pincus H, Walters E, Wang P, Wells K, Zaslavsky A (2005) Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 352: 2515–2523

    Article  PubMed  CAS  Google Scholar 

  18. Murray C, Lopez A (1997) Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 349:1498–1504

    Article  PubMed  CAS  Google Scholar 

  19. Oldehinkel A, Wittchen H-U, Schuster P (1999) Prevalence, 20-month incidence and outcome of unipolar depressive disorders in a community sample of adolescents. Psychol Med 29:655–668

    Article  PubMed  CAS  Google Scholar 

  20. Ostler K, Thompson C, Kinmonth A-L, Peveler R, Stevens L, Stevens A (2001) Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care. The Hampshire depression project. Br J Psychiatry 178:12–17

    Article  PubMed  CAS  Google Scholar 

  21. Palsson S, Östling S, Skoog I (2001) The incidence of first-onset depression in a population followed from the age 70 to 85. Psychol Med 31:1159–1168

    Article  PubMed  CAS  Google Scholar 

  22. Parikh S, Lesage A, Kennedy S, Goering P (1999) Depression in Ontario: under-treatment and factors related to antidepressant use. J Affect Dis 67–76

  23. Regier D, Farmer M, Rae D, Myers J, Kramer M, Robins L, George L, Karno M, Locke B (1993) One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the epidemiologic catchment area study. Acta Psychiatr Scand 88:35–47

    PubMed  CAS  Google Scholar 

  24. Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen (2001) Depressive Störungen. In: Gutachten 2000/2001: Bedarfsgerechtigkeit und Wirtschaftlichkeit, Ausführliche Zusammenfassung. Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen, pp 169–177

  25. Stordal E, Mykletun A, Dahl A (2003) The association between age and depression in the general population: a multivariate examination. Acta Psychiatr Scand 107:132–142

    Article  PubMed  CAS  Google Scholar 

  26. Whittington C, Kendall T, Fonagy P, Cotrell D, Cotgrove A, Boddington E (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:11341–11345

    Article  Google Scholar 

  27. Wittchen H-U, Hofler M, Meister W (2001) Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? Int Clin Psychopharmacol 16:121–135

    Article  CAS  Google Scholar 

  28. Wittchen H-U, Jacobi F (2006) Epidemiologie. In: Stoppe G, Bramesfeld A, Schwartz F (eds) Volkskrankheit Depression? Bestandsaufnahme und Perspektiven. Springer, Berlin, Heidelberg, pp 15–37

  29. Wittchen H-U, Müller N, Pfisterer H, Winter S, Schmidtkurz B (1999) Affektive, somatoforme und Angsstörungen in Deutschland—Erste Ergebnisse des bundesweiten Zusatzsurveys “Psychische Störungen”. Gesundheitswesen 61:216–222

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. for Epidemiology, Social Medicine, and Health System Research, Medical School Hannover, OE 5410, Carl Neunberg Straße 1, 30625, Hannover, Germany

    Anke Bramesfeld & Friedrich Wilhelm Schwartz

  2. Institute for Social Medicine, Epidemiology and Health System Research (ISEG), Hannover, Germany

    Thomas Grobe

Authors
  1. Anke Bramesfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Grobe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Friedrich Wilhelm Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anke Bramesfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bramesfeld, A., Grobe, T. & Schwartz, F.W. Who is treated, and how, for depression?. Soc Psychiat Epidemiol 42, 740–746 (2007). https://doi.org/10.1007/s00127-007-0225-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00127-007-0225-9

Key words

Search

Navigation